P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents
申请人:Krauss Elisabeth Nancy
公开号:US20060173075A1
公开(公告)日:2006-08-03
This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents
申请人:Syntex (U.S.A.) LLC
公开号:US07071177B2
公开(公告)日:2006-07-04
This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
[EN] P-(SULFONYL)ARYL AND HETEROARYLS<br/>[FR] P-(SULFONYL)ARYLE ET HETEROARYLES
申请人:HOFFMANN LA ROCHE
公开号:WO2001083434A2
公开(公告)日:2001-11-08
This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds. The claimed compounds have prostaglandin G/H synthase inhibitor activity and are suitable for the treatment of inflammatory diseases, such as myositis, synovitis, rheumatoid arthritis, osteoarthritis, gout, ankylosing spondylitis and bursitis, for the treatment of Alzheimer's disease or of an autoimmune disease such as systemic lupus erythematosus and type I diabetes.